Newsletter

Good morning everyone.  Today I’m watching a small cap that delivered the kind of news we usually only see from large caps. This is the first chance for traders to buy since the company announced that it will start buying up to 10 million shares of its own stock. That means today we could see a big move in MFTH – Medisafe 1 Technologies.

Because this morning will represent the first chance traders will get to have a crack at MFTH after they announced this huge news, MFTH is setup for a huge increase in volume today, and possibly a big ONE DAY POP perfect for a quick trade.

MFTH has shown it can double or more in a single day, so this one is just what the day traders are looking for.

If MFTH has a strong day and carries on with yesterday's upward momentum, we could see a huge surge.  This is one you definitely want to have on the TOP of your momentum watchlist to see if it gets hot today.

Medisafe 1 Technologies Corp. is a development stage company that is working on a commercial application for its patented device that helps hospitals avoid errors. The Protector is used for administering medicine while reducing the chance of potentially deadly errors. It is a device that is used to lock a syringe to make sure only the right patient gets the medicine. A barcode on the patient’s wristband unlocks the syringe if it matches the information loaded into the Protector. Without a match, the patient can’t get that shot and this little device avoids a potentially fatal error.

MFTH owns the patent for this hypodermic syringe safety device!

This is the world’s first US patented technology to eliminate the administration of incorrect medicinal substances by hypodermic needle.

Hospitals make a surprising number of errors given how high the stakes are. According to a report from the Institute of Medicine, there is at least one medication error per hospital patient per day. There are 400,000 preventable drug related injuries every year and up to 98,000 Americans die each year due to medical errors by healthcare professionals. The total cost of all these preventable drug related mistakes is $177.4 billion.

MFTH estimates the Protector can help save $1.4 billion of the medical costs associated with errors in the US alone. This product may also save lives.

The company owns the world's first patented technology that can almost completely prevent giving the wrong medicine to a patient. In their own words, MFTH is working to make sure that healthcare professionals “administer the right drug with the right dose to the right patient at the right time.”

There is already a fully operational prototype. This is the stage where some companies can run out of money since getting from patent to product can be expensive. But MFTH developed a fully operational working prototype with PIA Electronics Ltd, granting PIA Electronics a commission of 10% of all future royalties from the sale and licensing of the technology based on the working prototype. This kind of strategy could help MFTH get to market and profitability quicker than if they were trying to do everything themselves.

In addition to marketing the Protector, MFTH will also be looking at acquisitions of other companies that make medical devices or lifesaving technologies. They are only interested in products that are already generating revenue, showing that they are staying focused on profitability.

Company officials haven’t released any specific details about future acquisitions, but they did say they are negotiating to acquire a company that makes a child life-saving medical device.

The team running MFTH seems to be thinking about three very important objectives – revenue, profitability and shareholder-value.

We don’t often see a small cap company announce a buy back of its stock. It means management has evaluated what the company is really worth and decided the stock is currently far below that price.

MFTH has said they will buy back up to 10 million-shares and they are willing to pay as much as 10 cents a share. That’s 456% more than yesterday’s closing price of 1.8 cents.

No one knows a company better than the management team and the Board of Directors. If they say the stock is worth up to 10 cents a share, there must be a reason for them to believe that. They haven’t told investors what their reason is, but they are working on acquisitions and marketing plans for an incredible lifesaving device.

After yesterday’s close, the company said they want to start buying and they’ll be making the first purchases in March. This buyback could provide a floor under the stock price since the company could possibly be buying when it’s cheap.

MFTH has traded some big volume in the recent past, and seems to be gaining some interest from traders.

Besides volume, traders need volatility and MFTH has that also. Yesterday the stock gained 64% and closed right at the high, a bullish signal that means there could be some follow through today. Last month, we saw a one day, 207% move in this stock on small volume.

The high in January was 3.9 cents a share, so this stock could gain 117% before hitting the price investors were willing to pay for it a few weeks ago. And that high was reached before the company bought any shares of its stock. Now that the company says that they will be buying, there could be even more buying volume for MFTH and buying is what makes share prices go up.

There is strong momentum in the stock, with MACD ready to say ‘buy’ and RSI moving higher to confirm the signal.  It's also rated a Strong-Buy on barchart.com.

http://barchart.com/quotes/stocks/MFTH

As I've said this doesn't really mean anything, but it does definitely attract more traders and buying.  Inspires confidence.  You know, people think it's a Strong-Buy so it becomes a strong-buy.  Take the blue pill Neo...

As I said last night, MFTH is a risky play.  It has a very low share price, which always means extra volatility.  Plus it made a massive upward move yesterday.  You know what these kinds of alerts do after a monster gain.  They either keep running and expand on the momentum, or they pullback to earth and crash hard. 

Be sure you are prepared for either.  It closed at the high so that's very bullish, but this is one you want to watch carefully to make sure it's trading nice and healthy with upward momentum, because if momentum fizzles out...   :(

Watch out for gaps.  Use a tight stop.  Trade with caution, book profits while you can.

But of course I'd never send out such a risky proposition if the gain potential wasn't worth it. 

The chart shows MFTH could possibly fly as high as a DOUBLE or more within a single day!

We had a 64% gain yesterday and the price closed at the high. After that, we got big news from the company. That's quite a bullish combo, especially with the chart being hot too.

I've scoured the entire penny markets and MFTH looks like the single biggest upside-potential trade for the day.

Watch MFTH like a hawk at today's open!

PSA - Stock Psycho

www.pennystockalerts.com

Don’t ever invest based on what I say, do your own research and consult with a licensed professional before investing, only invest what you are prepared to lose. Any statements and opinions given are amateur and biased and should be treated as such. Past performance does not indicate future performance in any way. Check the latest SEC filings before investing, and research other information on the risks of investing in penny stocks at www.sec.gov

READ IMPORTANT DISCLAIMER

Disclaimer – This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by IPR Agency LLC, a California Limited Liability Company. Any reference to “we” or “our” refers to IPR Agency LLC. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore unqualified to give investment recommendations. Always do your own research and consult with an licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on EOD or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices.  We have been compensated up to forty five thousand dollars cash via bank wire to conduct two days of investor relations marketing for MFTH by a third party, Hapisga Change – Adler Albert.  This is currently active. In May of 2011 we were compensated thirty thousand dollars cash via bank wire to conduct two days of investor relations marketing fo MFTH by a different third party, Royal Import Inc, which has expired.  All of this compensation, expired or not, is a major conflict of interest in our ability to be unbiased regarding the company(s) discussed in our alerts. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the third party or parties. The third party, profiled company, or affiliates of either likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. IPR Agency LLC never owns a position in the companies discussed in our communications, email or otherwise, unless otherwise stated in this disclaimer. We have not been compensated in any way for the mention of any other companies named in this communication, and we own no position in any of them. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forword looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way to ensure the publicly available information is correct. Furthermore, IPR Agency LLC often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at www.pennystockalerts.com/disclaimer